LMR Partners’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,671
Closed -$213K 929
2024
Q3
$213K Buy
+3,671
New +$213K ﹤0.01% 510
2024
Q2
Sell
-3,671
Closed -$243K 836
2024
Q1
$243K Buy
+3,671
New +$243K ﹤0.01% 426
2023
Q4
Sell
-27,245
Closed -$869K 773
2023
Q3
$869K Hold
27,245
0.01% 331
2023
Q2
$1.09M Buy
27,245
+3,574
+15% +$144K 0.01% 302
2023
Q1
$1.01M Buy
+23,671
New +$1.01M 0.02% 588